三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02197 三叶草生物-B

未开盘 12-23 16:08:41

0.249

-0.001

-0.40%

最高0.250	最低0.244	成交量95.55万
今开0.249	昨收0.250	日振幅2.40%
总市值3.23亿	流通市值3.23亿	总股本12.97亿
成交额23.56万	换手率0.07%	流通股本12.97亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02197","market":"HK","secType":"STK","nameCN":"三叶草生物-B","latestPrice":0.249,"timestamp":1734941321011,"preClose":0.25,"halted":0,"volume":955500,"delay":0,"floatShares":1297048929,"shares":1297048929,"eps":-0.118469164,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.001,"latestTime":"12-23 16:08:41","open":0.249,"high":0.25,"low":0.244,"amount":235607,"amplitude":0.024,"askPrice":0.25,"askSize":20000,"bidPrice":0.249,"bidSize":15500,"shortable":0,"etf":0,"ttmEps":-0.7547297282129786,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"listingDate":1636041600000,"adjPreClose":0.25,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":1.4338730181274897,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02197","defaultTab":"news","newsList":[{"id":"2492973452","title":"港股生物技术板块尾盘走强，歌礼制药(01672.HK)涨超15%，圣诺医药(02257.HK)涨超9%，再鼎医药(09688.","url":"https://stock-news.laohu8.com/highlight/detail?id=2492973452","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492973452?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:31","pubTimestamp":1734507119,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4548","BK4585","01477","YANG","09688","ZLAB","01672","BK1588","02257","BK1515","07226","HSCEI","BK1191","BK4526","02197","BK1161","BK4588","HSTECH","BK1574","LU2488822045.USD","BK4139","BK4531"],"gpt_icon":0},{"id":"2491463237","title":"三叶草生物-B盘中异动 快速下跌5.56%报0.255港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491463237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491463237?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:09","pubTimestamp":1734329390,"startTime":"0","endTime":"0","summary":"2024年12月16日下午盘14时09分，三叶草生物-B股票出现波动，股价快速跳水5.56%。截至发稿，该股报0.255港元/股，成交量32.6万股，换手率0.03%，振幅5.56%。资金方面，该股资金流入9230港元，流出7.58675万港元。三叶草生物-B股票所在的生物技术行业中，整体跌幅为1.18%。其相关个股中，晶泰控股-P、华康生物医学、嘉和生物-B涨幅较大，振幅较大的相关个股有晶泰控股-P、创胜集团-B、思路迪医药股份，振幅分别为18.53%、18.03%、16.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216140950a1f23365&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216140950a1f23365&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02197","BK1161"],"gpt_icon":0},{"id":"2489547778","title":"三叶草生物-B盘中异动 下午盘急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489547778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489547778?lang=zh_cn&edition=full","pubTime":"2024-12-06 14:18","pubTimestamp":1733465890,"startTime":"0","endTime":"0","summary":"2024年12月06日下午盘14时18分，三叶草生物-B股票出现波动，股价急速拉升5.45%。截至发稿，该股报0.290港元/股，成交量31.05万股，换手率0.02%，振幅5.45%。三叶草生物-B股票所在的生物技术行业中，整体涨幅为1.70%。其相关个股中，北海康成-B、晶泰科技、药明康德涨幅较大，振幅较大的相关个股有北海康成-B、晶泰科技、来凯医药-B，振幅分别为63.08%、14.60%、13.75%。该公司的主营业务是为传染性疾病以及癌症及自身免疫性疾病开发新型疫苗及生物治疗候选产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206141810971c0d85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206141810971c0d85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2485408973","title":"三叶草生物-B盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485408973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485408973?lang=zh_cn&edition=full","pubTime":"2024-11-22 10:12","pubTimestamp":1732241534,"startTime":"0","endTime":"0","summary":"2024年11月22日早盘10时12分，三叶草生物-B股票出现异动，股价大幅下跌5.08%。截至发稿，该股报0.280港元/股，成交量32.15万股，换手率0.02%，振幅5.08%。三叶草生物-B股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，来凯医药-B、宜明昂科-B、荃信生物-B涨幅较大，振幅较大的相关个股有华领医药-B、来凯医药-B、宜明昂科-B，振幅分别为16.67%、13.83%、9.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122101215abd61e2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122101215abd61e2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2482797649","title":"三叶草生物-B盘中异动 快速拉升6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482797649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482797649?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:45","pubTimestamp":1731375940,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘09时45分，三叶草生物-B股票出现异动，股价急速拉升6.35%。截至发稿，该股报0.335港元/股，成交量61.3万股，换手率0.05%，振幅9.52%。三叶草生物-B股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，瑞科生物-B、方达控股、乐普生物-B涨幅较大，振幅较大的相关个股有绿竹生物-B、和誉-B、科济药业-B，振幅分别为18.42%、12.23%、9.22%。该公司的主营业务是为传染性疾病以及癌症及自身免疫性疾病开发新型疫苗及生物治疗候选产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112094540a22e174b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112094540a22e174b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2482460615","title":"高价收技术，持续巨亏！探秘天价股权激励背后的故事","url":"https://stock-news.laohu8.com/highlight/detail?id=2482460615","media":"星空财研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482460615?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:25","pubTimestamp":1730971523,"startTime":"0","endTime":"0","summary":"大家都知道，国内在生物医药领域和头部国家们还有较大的差距，不过近些年来在不少细分领域，国内企业奋起直追，在极个别领域中取得了先发优势。来自北京的泽辉生物科技有限公司（简称：泽辉生物）就是一家拥有一定....","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241107A078B300","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241107A078B300","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK4139","PSC","02257","BK1161","ARDS","02197"],"gpt_icon":0},{"id":"2481401149","title":"三叶草生物-B盘中异动 股价大涨6.67%报0.320港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481401149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481401149?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:25","pubTimestamp":1730964327,"startTime":"0","endTime":"0","summary":"2024年11月07日下午盘15时25分，三叶草生物-B股票出现异动，股价大幅拉升6.67%。截至发稿，该股报0.320港元/股，成交量249万股，换手率0.19%，振幅8.33%。资金方面，该股资金流入43.2148万港元，流出29.7417万港元。三叶草生物-B股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，科济药业-B、正大企业国际、昭衍新药涨幅较大，振幅较大的相关个股有科济药业-B、百奥赛图-B、北海康成-B，振幅分别为45.67%、17.38%、17.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152527971a502a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152527971a502a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"gpt_icon":1},{"id":"2480783810","title":"三叶草生物-B盘中异动 下午盘急速上涨5.00%报0.315港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480783810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480783810?lang=zh_cn&edition=full","pubTime":"2024-11-01 15:19","pubTimestamp":1730445565,"startTime":"0","endTime":"0","summary":"2024年11月01日下午盘15时19分，三叶草生物-B股票出现异动，股价快速拉升5.00%。截至发稿，该股报0.315港元/股，成交量139.7万股，换手率0.11%，振幅6.67%。资金方面，该股资金流入25.4655万港元，流出16.492万港元。三叶草生物-B股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，华昊中天医药-B、荣昌生物、方达控股涨幅较大，振幅较大的相关个股有华昊中天医药-B、科济药业-B、方达控股，振幅分别为23.56%、19.25%、18.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101151925971a3cbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101151925971a3cbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2480605016","title":"三叶草生物-B（02197）SCB-1019：潜在同类最佳，重塑全球RSV市场格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2480605016","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480605016?lang=zh_cn&edition=full","pubTime":"2024-11-01 08:45","pubTimestamp":1730421915,"startTime":"0","endTime":"0","summary":"很快，2024年4月和6月三叶草生物分别披露其二价RSV候选疫苗SCB-1019 Ⅰ期临床试验在年轻成年人和老年人群组获得积极初步数据。短短四个月后，三叶草生物又成为全球首家公布其RSV候选疫苗与已获批商业化的国际龙头RSV疫苗产品头对头临床试验结果的厂家，引来全球同行及资本市场的高度关注。表明，SCB-1019的耐受性总体良好，且SCB-1019的局部和全身不良事件总体较轻，与生理盐水安慰剂组相当。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK1161"],"gpt_icon":0},{"id":"2479577854","title":"三叶草生物-B(02197)下跌6.35%，报0.295元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479577854","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479577854?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:43","pubTimestamp":1730360601,"startTime":"0","endTime":"0","summary":"10月31日，三叶草生物-B(02197)盘中下跌6.35%，截至15:43，报0.295元/股，成交102.27万元。三叶草生物制药有限公司是一家全球性的临床阶段生物技术公司，主要业务是开发新型疫苗及生物治疗候选产品，以解决全球最危及生命的疾病及公共卫生威胁。公司的关键经营数据是其独有的Trimer-Tag专利技术平台，该平台使其成为领先的COVID-19候选疫苗开发商，并可能成为全球首家商业化COVID-19重组蛋白疫苗的公司。截至2024年中报，三叶草生物-B营业总收入-1010.0万元、净利润-9512.3万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/31154344781580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02197","BK1161"],"gpt_icon":0},{"id":"2479747209","title":"三叶草生物-B盘中异动 快速下挫6.35%报0.295港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479747209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479747209?lang=zh_cn&edition=full","pubTime":"2024-10-31 13:33","pubTimestamp":1730352821,"startTime":"0","endTime":"0","summary":"2024年10月31日下午盘13时33分，三叶草生物-B股票出现波动，股价快速下跌6.35%。截至发稿，该股报0.295港元/股，成交量190.6万股，换手率0.15%，振幅9.52%。资金方面，该股资金流入3.281万港元，流出53.4532万港元。三叶草生物-B股票所在的生物技术行业中，整体跌幅为1.12%。其相关个股中，华昊中天医药-B、中生北控生物科技、科笛-B涨幅较大，振幅较大的相关个股有中生北控生物科技、华昊中天医药-B、方达控股，振幅分别为100.00%、37.19%、14.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031133341971a36ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031133341971a36ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"gpt_icon":1},{"id":"2479419169","title":"港股医药股再获资金关注 三叶草生物大涨近15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479419169","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479419169?lang=zh_cn&edition=full","pubTime":"2024-10-29 11:05","pubTimestamp":1730171100,"startTime":"0","endTime":"0","summary":"财联社10月29日讯 今日港股医药股多数走强。截至发稿，三叶草生物-B、宜明昂科-B、贝康医疗-B、药明康德分别上涨14.75%、7.83%、7.48%、4.08%。　　消息方面，目前2024年医保谈判已进入谈判/竞价阶段。建议以最终品种名单为准。　　从上图来看，三叶草生物和宜明昂科涨幅居前。　　其次，宜明昂科发布公告称，2024年10月25日，该公司已就拟实施H股全流通向中国证监会提交备案文件，以转换合共1411.4万股公司未上市股份为公司H股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2024-10-29/doc-incuetka2097941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","159718","02197"],"gpt_icon":0},{"id":"2479134184","title":"港股医药股多数走强 宜明昂科涨超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479134184","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479134184?lang=zh_cn&edition=full","pubTime":"2024-10-29 10:35","pubTimestamp":1730169338,"startTime":"0","endTime":"0","summary":"南方财经10月29日电，截至发稿，宜明昂科-B(01541.HK)涨15.11%、三叶草生物-B(02197.HK)涨14.75%、贝康医疗-B(02170.HK)涨7.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202410293220959278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02197","BK1597","01541","02170","BK1222","BK1574"],"gpt_icon":0},{"id":"2479492863","title":"港股异动 | 三叶草生物-B(02197)涨超14% 二价RSV疫苗I期研究结果积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2479492863","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479492863?lang=zh_cn&edition=full","pubTime":"2024-10-29 09:43","pubTimestamp":1730166209,"startTime":"0","endTime":"0","summary":"三叶草生物-B(02197)涨超14%，截至发稿，涨14.75%，报0.35港元，成交额83.56万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20241029/20241029094411_43795.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241029/20241029094411_43795.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02197","BK1161","159646"],"gpt_icon":0},{"id":"2479921344","title":"三叶草生物－Ｂ(02197)股价显著上升14.754%，现价港币$0.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2479921344","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479921344?lang=zh_cn&edition=full","pubTime":"2024-10-29 09:35","pubTimestamp":1730165700,"startTime":"0","endTime":"0","summary":"[上升股]三叶草生物－Ｂ(02197) 股价在上午09:35比前收市价显著上升14.754%，现股价为港币$0.35。至目前为止，今日最高价为$0.35，而最低价为$0.32。总成交量为122.05万股，总成交金额为港币$40.898万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241029334/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2479049279","title":"三叶草生物-B盘中异动 早盘股价大涨8.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479049279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479049279?lang=zh_cn&edition=full","pubTime":"2024-10-29 09:30","pubTimestamp":1730165408,"startTime":"0","endTime":"0","summary":"2024年10月29日早盘09时30分，三叶草生物-B股票出现波动，股价急速拉升8.20%。截至发稿，该股报0.330港元/股，成交量10.45万股，换手率0.01%，振幅3.28%。三叶草生物-B股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，锦欣生殖、三叶草生物-B、药明合联涨幅较大，振幅较大的相关个股有锦欣生殖、三叶草生物-B、康诺亚-B，振幅分别为4.15%、3.28%、2.09%。该公司的主营业务是为传染性疾病以及癌症及自身免疫性疾病开发新型疫苗及生物治疗候选产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102909300898e3ef13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102909300898e3ef13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2479849325","title":"三叶草生物(02197.HK)二价RSV候选疫苗与GSKRSV疫苗头对头比较 在老年人受试者中获积极临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2479849325","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479849325?lang=zh_cn&edition=full","pubTime":"2024-10-29 08:14","pubTimestamp":1730160840,"startTime":"0","endTime":"0","summary":"三叶草生物公布，在Ⅰ期临床试验中评估未使用佐剂的二价RSV PreF－三聚体亚单位候选疫苗SCB-1019 与GSK使用AS01E佐剂的RSV疫苗AREXVY进行头对头比较后，在老年人受试者中获得更多积极的免疫原性和安全性数据。与GSK使用AS01E佐剂的RSV疫苗AREXVY相比，未使用佐剂的SCB1019的局部不良事件发生率明显较低。SCB-1019的耐受性总体良好。未观察到与疫苗相关的严重不良事件，特殊关注的不良事件或局部不良事件导致的停药。(港股报价延迟最少十五分钟。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220113153515477_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220113153515477_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1391799/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02197","BK1161","159646"],"gpt_icon":0},{"id":"2479464809","title":"三叶草生物公布其二价 RSV 候选疫苗 SCB-1019 与 GSK RSV 疫苗 AREXVY 头对头比较获得积极临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2479464809","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479464809?lang=zh_cn&edition=full","pubTime":"2024-10-29 06:30","pubTimestamp":1730154600,"startTime":"0","endTime":"0","summary":"在正在进行的 Ⅰ 期临床试验中，70例老年受试者入组了临床试验，分别接种了三叶草生物的 SCB-1019、GSK 的 AREXVY 或生理盐水安慰剂。RSV-B 中和抗体：接种后第 28 天，SCB-1019 诱导的 RSV-B 中和抗体几何平均滴度约为32,000 IU/mL，而 AREXVY 组数据约为 37,700 IU/mL，安慰剂组数据约为 2,900 IU/mL。SCB-1019 的耐受性总体良好。基于上述积极的 Ⅰ 期临床试验结果，三叶草生物计划将在 2025 年启动临床试验，用于评估 SCB-1019在 RSV 疫苗重复接种以及呼吸道联合疫苗的应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4541781_ZH41781_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4007","BK1161","02197","GSK","BK4588","GSK.UK","LU1829250122.USD","BK4532","BK4585"],"gpt_icon":0},{"id":"2479690514","title":"三叶草生物-B(02197)：二价RSV候选疫苗SCB-1019与GSKRSV疫苗AREXVY头对头比较获得积极临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2479690514","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479690514?lang=zh_cn&edition=full","pubTime":"2024-10-29 06:21","pubTimestamp":1730154078,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B 发布公告，在Ⅰ期临床试验中评估未使用佐剂的二价RSV PreF-三聚体亚单位候选疫苗SCB-1019与GSK使用AS01E佐剂的RSV疫苗AREXVY进行头对头比较后，在老年人受试者中获得了更多积极的免疫原性和安全性数据。在正在进行的Ⅰ期临床试验中，70例老年受试者入组了临床试验，分别接种了三叶草生物的SCB-1019、GSK的AREXVY或生理盐水安慰剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK1161","159646"],"gpt_icon":0},{"id":"2477320428","title":"三叶草生物-B盘中异动 股价大跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477320428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477320428?lang=zh_cn&edition=full","pubTime":"2024-10-23 14:31","pubTimestamp":1729665093,"startTime":"0","endTime":"0","summary":"2024年10月23日下午盘14时31分，三叶草生物-B股票出现波动，股价大幅下跌6.06%。截至发稿，该股报0.310港元/股，成交量56.8万股，换手率0.04%，振幅7.58%。资金方面，该股资金流入6.5265万港元，流出10.416万港元。三叶草生物-B股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，云顶新耀-B、来凯医药-B、宜明昂科-B涨幅较大，振幅较大的相关个股有云顶新耀-B、来凯医药-B、永泰生物-B，振幅分别为21.19%、19.41%、14.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023143133ab6c74da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023143133ab6c74da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02197","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0423},{"period":"1month","weight":-0.1107},{"period":"3month","weight":0.0462},{"period":"6month","weight":-0.3083},{"period":"1year","weight":-0.5554},{"period":"ytd","weight":-0.5984}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0464},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.1663}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.145243},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.102031},{"month":3,"riseRate":0,"avgChangeRate":-0.190588},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.057695},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.199321},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.054856},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.118227},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.050562},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.11184},{"month":10,"riseRate":0,"avgChangeRate":-0.084217},{"month":11,"riseRate":0.666667,"avgChangeRate":0.686302},{"month":12,"riseRate":0.25,"avgChangeRate":-0.162411}],"exchange":"SEHK","name":"三叶草生物-B","nameEN":"CLOVER BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三叶草生物-B,02197,三叶草生物-B股票,三叶草生物-B股票老虎,三叶草生物-B股票老虎国际,三叶草生物-B行情,三叶草生物-B股票行情,三叶草生物-B股价,三叶草生物-B股市,三叶草生物-B股票价格,三叶草生物-B股票交易,三叶草生物-B股票购买,三叶草生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}